AlphaCentric Advisors LLC
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed April 24, 2024), AlphaCentric Advisors LLC reported 228 stock positions worth $165.8 million. Its top holding was Pfizer (PFE) at 2.9% of the portfolio, followed by Rithm Capital (RITM, 2.8%) and Harmony Biosciences (HRMY, 2.5%). Compared with Q4 2023, it opened 38 new positions, sold out of 26, added to 43 and reduced 118. The biggest buy was a new position in United Therapeutics (UTHR) and the biggest sale an exit from Immunogen (IMGN).
- Most Recent 13F
- Q2 2026
- Location
- SAN JUAN, PR
- CIK
- 0001913464
- Portfolio Value
- $165.8M (Q1 2024)
- SEC Filing
- 0001162044-24-000403 ↗ filed Apr 24, 2024
Holdings Value
Holdings 228 stocks · $165.8M
| PFE Pfizer Inc. | 2.93% | 175,000 | $4.9M | Add +118.8% |
| RITM Rithm Capital Corp. | 2.83% | 420,966 | $4.7M | Add +5.0% |
| HRMY Harmony Biosciences Holdings | 2.47% | 122,000 | $4.1M | No change |
| UTHR United Therapeutics Corp. | 2.22% | 16,000 | $3.7M | New |
| PCRX Pacira Biosciences Inc. | 2.07% | 117,500 | $3.4M | No change |
| BCRX Biocryst Pharmaceuticals Inc. | 2.07% | 675,000 | $3.4M | No change |
| LKFT Lakefront Biotherapeutic-ADR filed as GALAPAGOS NV | 2.04% | 105,000 | $3.4M | No change |
| ARGX Argenx SE - ADR | 1.90% | 8,000 | $3.1M | Add +3.2% |
| TWO HARBORS INV CORP (TWO 6.25 01/15/26) | 1.84% | 3,205,000 | $3.0M | No change |
| NARI Inari Medical Inc. | 1.82% | 63,000 | $3.0M | Add +1160.0% |
| DCGO Docgo Inc. | 1.58% | 650,000 | $2.6M | Add +109.7% |
| ONC Beone Medicines Ltd.-ADR filed as BEIGENE LTD | 1.58% | 16,750 | $2.6M | Add +123.3% |
| EFC Ellington Financial Inc. | 1.58% | 221,602 | $2.6M | No change |
| AXSM Axsome Therapeutics Inc. | 1.56% | 32,500 | $2.6M | New |
| MTG Mgic Investment Corp. | 1.54% | 114,379 | $2.6M | Add +44.1% |
| QURE Uniqure NV | 1.44% | 460,000 | $2.4M | Add +9.3% |
| CHRS Coherus Oncology Inc. | 1.44% | 1,000,000 | $2.4M | No change |
| MIRM Mirum Pharmaceuticals Inc. | 1.42% | 94,000 | $2.4M | Add +88.0% |
| DX Dynex Capital Inc. | 1.36% | 181,492 | $2.3M | No change |
| URGN Urogen Pharma Ltd. | 1.30% | 143,898 | $2.2M | Reduce -7.2% |
| CORT Corcept Therapeutics Inc. | 1.29% | 85,000 | $2.1M | New |
| CATX Perspective Therapeutics Inc. | 1.26% | 1,756,756 | $2.1M | New |
| FOLD Amicus Therapeutics Inc. | 1.24% | 175,000 | $2.1M | Add +25.0% |
| EXAS Exact Sciences Corp. | 1.21% | 29,000 | $2.0M | New |
| PENNYMAC CORP (PMT 5.5 11/01/24) | 1.17% | 1,965,000 | $1.9M | No change |
| MFA Mfa Financial Inc. | 1.15% | 167,725 | $1.9M | Add +17.5% |
| RWT Redwood Trust Inc. | 1.11% | 288,343 | $1.8M | Add +96.7% |
| RPRX Royalty Pharma PLC Class A | 1.10% | 60,000 | $1.8M | Add +50.0% |
| CERE Cerevel Therapeutics Holding | 1.08% | 42,500 | $1.8M | Add +70.0% |
| MDT Medtronic PLC | 1.08% | 20,500 | $1.8M | No change |
| KPTI Karyopharm Therapeutics Inc. | 1.02% | 1,125,000 | $1.7M | No change |
| CLDX Celldex Therapeutics Inc. | 0.97% | 38,500 | $1.6M | New |
| RPV Invesco S&P 500 Pure Value E | 0.95% | 17,834 | $1.6M | New |
| STXS Stereotaxis Inc. | 0.94% | 600,000 | $1.6M | No change |
| IWD iShares Russell 1000 Value E | 0.94% | 8,671 | $1.6M | New |
| KALV Kalvista Pharmaceuticals Inc. | 0.93% | 130,000 | $1.5M | Reduce -5.1% |
| DVAX Dynavax Technologies Corp. | 0.92% | 122,500 | $1.5M | Add +22.5% |
| GSK GSK PLC-Spon ADR | 0.91% | 35,000 | $1.5M | No change |
| BCYC Bicycle Therapeutics PLC-ADR | 0.90% | 60,000 | $1.5M | New |
| AVBP Arrivent Biopharma Inc. | 0.89% | 83,000 | $1.5M | New |
| EMBC Embecta Corp. | 0.89% | 111,500 | $1.5M | Reduce -44.3% |
| VKTX Viking Therapeutics Inc. | 0.89% | 18,000 | $1.5M | New |
| ADAM Adamas Trust Inc. | 0.87% | 200,963 | $1.4M | No change |
| SNPS Synopsys Inc. | 0.86% | 2,500 | $1.4M | Add +19.1% |
| TRML Tourmaline Bio Inc. | 0.84% | 61,100 | $1.4M | New |
| ITCI Intra-Cellular Therapies Inc. | 0.83% | 20,000 | $1.4M | No change |
| VYNE THERAPEUTICS INC | 0.82% | 445,000 | $1.4M | Reduce -33.4% |
| BMRN Biomarin Pharmaceutical Inc. | 0.82% | 15,500 | $1.4M | Add +10.7% |
| ELS Equity Lifestyle Properties | 0.80% | 20,611 | $1.3M | No change |
| ACT Enact Holdings Inc. | 0.80% | 42,367 | $1.3M | No change |
| MITT TPG Mortgage Investment Trus | 0.77% | 208,879 | $1.3M | No change |
| PRCT Procept Biorobotics Corp. | 0.75% | 25,000 | $1.2M | New |
| IMVT Immunovant Inc. | 0.74% | 38,000 | $1.2M | No change |
| AVAV Aerovironment Inc. | 0.74% | 8,000 | $1.2M | New |
| RVNC Revance Therapeutics Inc. | 0.73% | 245,000 | $1.2M | Add +11.4% |
| ISRG Intuitive Surgical Inc. | 0.72% | 3,000 | $1.2M | Reduce -20.0% |
| GPCR Structure Therapeutics Inc. | 0.71% | 27,500 | $1.2M | Reduce -8.3% |
| SOUN Soundhound AI Inc. Class A | 0.71% | 200,000 | $1.2M | No change |
| SYM Symbotic Inc. | 0.68% | 25,000 | $1.1M | No change |
| CABA Cabaletta Bio Inc. | 0.67% | 65,000 | $1.1M | New |
| JAZZ Jazz Pharmaceuticals PLC | 0.62% | 8,500 | $1.0M | Reduce -19.1% |
| SGMT Sagimet Biosciences Inc. Class A | 0.60% | 185,000 | $1.0M | New |
| RWT HOLDINGS INC (RWT 5.75 10/01/25) filed as RWT HLDGS INC | 0.59% | 1,000,000 | $970K | Reduce -56.2% |
| NBIX Neurocrine Biosciences Inc. | 0.58% | 7,000 | $965K | New |
| ROIV Roivant Sciences Ltd. | 0.57% | 90,000 | $949K | Add +63.6% |
| DCPH Deciphera Pharmaceuticals Inc. | 0.57% | 60,000 | $944K | New |
| LUNR Intuitive Machines Inc. | 0.57% | 150,000 | $938K | New |
| VRNA Verona Pharma Ltd. | 0.54% | 56,000 | $901K | No change |
| RRX Regal Rexnord Corp. | 0.54% | 5,000 | $901K | New |
| ALNT Allient Inc. | 0.54% | 25,000 | $892K | New |
| ARAY Accuray Inc. | 0.52% | 350,000 | $865K | New |
| AGNC AGNC Investment Corp. | 0.51% | 84,646 | $838K | No change |
| ACAD Acadia Pharmaceuticals Inc. | 0.50% | 45,000 | $832K | Add +73.1% |
| SNY Sanofi-ADR | 0.44% | 15,000 | $729K | New |
| PTGX Protagonist Therapeutics Inc. | 0.44% | 25,000 | $723K | Reduce -16.7% |
| ONIT Onity Group Inc. filed as OCWEN FINL CORP | 0.42% | 25,567 | $691K | Reduce -9.3% |
| GMED Globus Medical Inc. Class A | 0.40% | 12,500 | $671K | New |
| DYN Dyne Therapeutics Inc. | 0.34% | 20,000 | $568K | New |
| PCAR Paccar Inc. | 0.31% | 4,146 | $514K | Reduce -10.2% |
| BBJP JPMorgan Betabuilders Japan | 0.31% | 8,747 | $512K | Reduce -8.4% |
| EWA iShares MSCI Australia ETF | 0.31% | 20,694 | $510K | Add +2.5% |
| CAH Cardinal Health Inc. | 0.31% | 4,546 | $509K | Reduce -10.0% |
| QQQ Invesco QQQ Trust Series 1 | 0.30% | 1,128 | $501K | Reduce -78.0% |
| QQQM Invesco Nasdaq 100 ETF | 0.30% | 2,740 | $501K | Reduce -78.0% |
| AGMIT MERGER SUB LLC (MITT 6.75 09/15/24) | 0.30% | 500,000 | $497K | No change |
| VALN Valneva SE - ADR | 0.30% | 62,004 | $495K | Add +80.8% |
| NUVB Nuvation Bio Inc. | 0.30% | 135,000 | $491K | Reduce -70.0% |
| REDWOOD TRUST INC (RWT 7.75 06/15/27) | 0.29% | 500,000 | $481K | No change |
| MBB iShares MBS ETF | 0.28% | 5,000 | $462K | New |
| SHY iShares 1-3 Year Treasury Bo | 0.27% | 5,458 | $446K | Reduce -51.9% |
| AUPH Aurinia Pharmaceuticals Inc. | 0.24% | 80,000 | $401K | Add +60.0% |
| COOP Mr Cooper Group Inc. | 0.23% | 4,931 | $384K | Reduce -77.2% |
| DAL Delta Air Lines Inc. | 0.23% | 7,932 | $380K | Reduce -11.8% |
| PHM Pultegroup Inc. | 0.23% | 3,132 | $378K | Reduce -11.8% |
| IEI iShares 3-7 Year Treasury Bo | 0.23% | 3,242 | $375K | Reduce -29.0% |
| VYM Vanguard High DVD Yield ETF | 0.23% | 3,088 | $374K | Reduce -8.0% |
| REM iShares Mortgage Real Estate | 0.22% | 15,954 | $371K | Add +1.1% |
| CWB SS SPDR BB Conv Sec ETF | 0.22% | 4,972 | $363K | Reduce -5.2% |
| DWX State Street SPDR S&P Intern | 0.22% | 10,316 | $363K | Reduce -1.0% |
| PBP Invesco S&P 500 Buywrite ETF | 0.22% | 16,127 | $363K | Reduce -3.5% |
Portfolio Sells Q4 2023 → Q1 2024
| IMGN Immunogen Inc. | Sold out | 0.00% | −2.54 |
| WBA Walgreens Boots Alliance Inc. | Sold out | 0.00% | −2.10 |
| ABVX Abivax SA-ADR | Sold out | 0.00% | −1.92 |
| IRWD Ironwood Pharmaceuticals Inc. | Sold out | 0.00% | −1.88 |
| EMBC Embecta Corp. | Reduce -44.3% | 0.89% | −1.65 |
| AMLX Amylyx Pharmaceuticals Inc. | Sold out | 0.00% | −1.49 |
| QQQM Invesco Nasdaq 100 ETF | Reduce -78.0% | 0.30% | −1.11 |
| QQQ Invesco QQQ Trust Series 1 | Reduce -78.0% | 0.30% | −1.11 |
| RWT HOLDINGS INC (RWT 5.75 10/01/25) | Reduce -56.2% | 0.59% | −0.85 |
| VSTM Verastem Inc. | Sold out | 0.00% | −0.82 |
| KRTX Karuna Therapeutics Inc. | Sold out | 0.00% | −0.74 |
| COOP Mr Cooper Group Inc. | Reduce -77.2% | 0.23% | −0.71 |
| MBLY Mobileye Global Inc. Class A | Sold out | 0.00% | −0.58 |
| OMCL Omnicell Inc. | Sold out | 0.00% | −0.51 |
| IRTC Irhythm Holdings Inc. | Sold out | 0.00% | −0.36 |
| SHY iShares 1-3 Year Treasury Bo | Reduce -51.9% | 0.27% | −0.36 |
| HOS Hornbeck Offshore Services I | Sold out | 0.00% | −0.34 |
| GILD Gilead Sciences Inc. | Reduce -58.8% | 0.15% | −0.31 |
| URGN Urogen Pharma Ltd. | Reduce -7.2% | 1.30% | −0.26 |
| VTRS Viatris Inc. | Sold out | 0.00% | −0.25 |
| JAZZ Jazz Pharmaceuticals PLC | Reduce -19.1% | 0.62% | −0.25 |
| VYNE THERAPEUTICS INC | Reduce -33.4% | 0.82% | −0.22 |
| KALV Kalvista Pharmaceuticals Inc. | Reduce -5.1% | 0.93% | −0.20 |
| ONIT Onity Group Inc. | Reduce -9.3% | 0.42% | −0.17 |
| DPRO Draganfly Inc. | Sold out | 0.00% | −0.16 |
| NUVB Nuvation Bio Inc. | Reduce -70.0% | 0.30% | −0.16 |
| CBAY Cymabay Therapeutics Inc. | Sold out | 0.00% | −0.16 |
| NNDM Nano Dimension Ltd. - ADR | Reduce -50.0% | 0.17% | −0.15 |
| IEI iShares 3-7 Year Treasury Bo | Reduce -29.0% | 0.23% | −0.13 |
| ISRG Intuitive Surgical Inc. | Reduce -20.0% | 0.72% | −0.13 |
| GPCR Structure Therapeutics Inc. | Reduce -8.3% | 0.71% | −0.11 |
| MQY BlackRock Muniyield Quality | Sold out | 0.00% | −0.04 |
| HUM Humana Inc. | Reduce -11.9% | 0.06% | −0.04 |
| MHD BlackRock Muniholdings Fund | Sold out | 0.00% | −0.04 |
| MUC BlackRock Munihold Ca QLTY | Sold out | 0.00% | −0.04 |
| MUJ BlackRock Munihold NJ QLTY | Sold out | 0.00% | −0.04 |
| BLE BlackRock Muni Inc. TR II | Sold out | 0.00% | −0.04 |
| XMUIX BlackRock Municipal Income | Sold out | 0.00% | −0.04 |
| NOTE Fiscalnote Holdings Inc. | Sold out | 0.00% | −0.04 |
| CCL Carnival Corp. | Reduce -11.9% | 0.09% | −0.04 |
| CAH Cardinal Health Inc. | Reduce -10.0% | 0.31% | −0.04 |
| CWB SS SPDR BB Conv Sec ETF | Reduce -5.2% | 0.22% | −0.03 |
| EIM Eaton Vance Municipal Bond | Sold out | 0.00% | −0.03 |
| NMCO Nuveen Municipal Credit Opp | Sold out | 0.00% | −0.03 |
| NDMO Nuveen Dynamic Municipal Opp | Sold out | 0.00% | −0.03 |
| PMM Franklin Managed Municipal I | Sold out | 0.00% | −0.03 |
| EMB iShares JP Morgan Usd Emergi | Reduce -3.3% | 0.22% | −0.03 |
| DWX State Street SPDR S&P Intern | Reduce -1.0% | 0.22% | −0.03 |
| CHTR Charter Communications Inc. Class A | Reduce -12.3% | 0.04% | −0.03 |
| ASXC Asensus Surgical Inc. | Reduce -16.7% | 0.03% | −0.03 |
Portfolio Buys Q4 2023 → Q1 2024
| UTHR United Therapeutics Corp. | New | 2.22% | +2.22 |
| NARI Inari Medical Inc. | Add +1160.0% | 1.82% | +1.61 |
| AXSM Axsome Therapeutics Inc. | New | 1.56% | +1.56 |
| PFE Pfizer Inc. | Add +118.8% | 2.93% | +1.38 |
| CORT Corcept Therapeutics Inc. | New | 1.29% | +1.29 |
| CATX Perspective Therapeutics Inc. | New | 1.26% | +1.26 |
| EXAS Exact Sciences Corp. | New | 1.21% | +1.21 |
| CLDX Celldex Therapeutics Inc. | New | 0.97% | +0.97 |
| RPV Invesco S&P 500 Pure Value E | New | 0.95% | +0.95 |
| IWD iShares Russell 1000 Value E | New | 0.94% | +0.94 |
| BCYC Bicycle Therapeutics PLC-ADR | New | 0.90% | +0.90 |
| AVBP Arrivent Biopharma Inc. | New | 0.89% | +0.89 |
| VKTX Viking Therapeutics Inc. | New | 0.89% | +0.89 |
| TRML Tourmaline Bio Inc. | New | 0.84% | +0.84 |
| PRCT Procept Biorobotics Corp. | New | 0.75% | +0.75 |
| AVAV Aerovironment Inc. | New | 0.74% | +0.74 |
| ONC Beone Medicines Ltd.-ADR | Add +123.3% | 1.58% | +0.67 |
| CABA Cabaletta Bio Inc. | New | 0.67% | +0.67 |
| SGMT Sagimet Biosciences Inc. Class A | New | 0.60% | +0.60 |
| NBIX Neurocrine Biosciences Inc. | New | 0.58% | +0.58 |
| DCPH Deciphera Pharmaceuticals Inc. | New | 0.57% | +0.57 |
| LUNR Intuitive Machines Inc. | New | 0.57% | +0.57 |
| RRX Regal Rexnord Corp. | New | 0.54% | +0.54 |
| ALNT Allient Inc. | New | 0.54% | +0.54 |
| ARAY Accuray Inc. | New | 0.52% | +0.52 |
| MTG Mgic Investment Corp. | Add +44.1% | 1.54% | +0.51 |
| SNY Sanofi-ADR | New | 0.44% | +0.44 |
| MIRM Mirum Pharmaceuticals Inc. | Add +88.0% | 1.42% | +0.43 |
| DCGO Docgo Inc. | Add +109.7% | 1.58% | +0.42 |
| GMED Globus Medical Inc. Class A | New | 0.40% | +0.40 |
| RWT Redwood Trust Inc. | Add +96.7% | 1.11% | +0.38 |
| CERE Cerevel Therapeutics Holding | Add +70.0% | 1.08% | +0.37 |
| RPRX Royalty Pharma PLC Class A | Add +50.0% | 1.10% | +0.34 |
| DYN Dyne Therapeutics Inc. | New | 0.34% | +0.34 |
| MBB iShares MBS ETF | New | 0.28% | +0.28 |
| ROIV Roivant Sciences Ltd. | Add +63.6% | 0.57% | +0.16 |
| AZO AutoZone Inc. | New | 0.14% | +0.14 |
| SNPS Synopsys Inc. | Add +19.1% | 0.86% | +0.14 |
| HCA HCA Healthcare Inc. | New | 0.13% | +0.13 |
| CBOE Cboe Global Markets Inc. | New | 0.12% | +0.12 |
| IMTX Immatics NV | New | 0.11% | +0.11 |
| IEF iShares 7-10 Year Treasury B | Add +140.3% | 0.18% | +0.10 |
| EPHE iShares MSCI Philippines ETF | New | 0.08% | +0.08 |
| EWM iShares MSCI Malaysia ETF | New | 0.07% | +0.07 |
| MFA Mfa Financial Inc. | Add +17.5% | 1.15% | +0.07 |
| BNY Bank of New York Mellon Corp. | New | 0.06% | +0.06 |
| ANET Arista Networks Inc. | New | 0.06% | +0.06 |
| VRDN Viridian Therapeutics Inc. | New | 0.06% | +0.06 |
| VALN Valneva SE - ADR | Add +80.8% | 0.30% | +0.06 |
| EIDO iShares MSCI Indonesia ETF | New | 0.05% | +0.05 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 259 | $118.0M | GILD, VRTX, INVH, AZN, ROIV |
| Q1 2026 | 252 | $100.1M | GILD, RPV, IWD, AZN, VRTX |
| Q4 2025 | 249 | $100.3M | GILD, INVH, MBB, EEFT, VRTX |
| Q4 2024 | 209 | $100.2M | LLY, UNH, JNJ, SHY, ABBV |
| Q3 2024 | 230 | $134.5M | RITM, HRMY, LKFT, MRK, EFC |
| Q2 2024 | 217 | $135.8M | UTHR, BCRX, RITM, PFE, HRMY |
| Q1 2024 | 228 | $165.8M | PFE, RITM, HRMY, UTHR, PCRX |